Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 14.95 |
| PEG Ratio (TTM) | N/A | 3.59 |
| P/S Ratio (TTM) | 9.84 | 3.59 |
| P/B Ratio (TTM) | N/A | 6.08 |
| P/FCF Ratio (TTM) | 12.08 | 9.09 |
| Price to 5YR AVG Earnings Ratio | N/A | 27.19 |
| Price to 5YR AVG FCF Ratio | N/A | -23.64 |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.34% | 2.61% |
| ROE (TTM) | 6.63% | 45.03% |
| Net Profit Margin (TTM) | 94.65% | 27.79% |
| ROIC 5YR AVG | N/A | 24.10% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | -25.27% | N/A |
| Revenue | N/A | -50.49% | N/A |
| Net Income | N/A | -26.51% | N/A |
| Cash Flow | N/A | -32.94% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 104.42 | 1.05 |
| Quick Ratio (TTM) | 74.97 | 0.34 |
| D/E Ratio (TTM) | 0.01 | 0.69 |
| Interest Coverage (TTM) | 5.43 | 22.85 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | N/A | 0.67 |
| LTL to 5YR AVG FCF | N/A | -2.25 |
| Shares Outstanding Growth 5YR AVG | N/A | 30.73% |